5-HT-moduline, a 5-HT(1B/1D) receptor endogenous modulator, interacts with dopamine release measured in vivo by microdialysis

European Journal of Pharmacology

Volumn 358, Issue 2, 1998, Pages 129-137

  Bentué Ferrer, Danièle ^a   Reymann, Jean Michel ^a   Rousselle, Jean Claude ^b   Massot, Olivier ^b   Bourin, Michel ^c   Allain, Hervé ^a   Fillion, Gilles ^b  

^a Inst de Rech Contre le Cancer IRCC   (France)

^b INSTITUT PASTEUR   (France)

^c UNIVERSITÉ DE NANTES   (France)

Author keywords

5 HT (5 hydroxytryptamine, serotonin); 5 HT moduline; CP 93,129; Dopamine; Microdialysis

Indexed keywords

3 (1,2,5,6 TETRAHYDRO 4 PYRIDYL)PYRROLO[3,2 B]PYRIDIN 5 ONE; 3 O METHYLDOPAMINE; DIHYDROXYPHENYLACETIC ACID; DOPAMINE; HOMOVANILLIC ACID; LEUCYLSERYLALANYLLEUCINE; SEROTONIN; SEROTONIN 1B RECEPTOR; SEROTONIN 1D RECEPTOR; TETRAPEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; SEROTONINERGIC TRANSMISSION;

ANIMALS; BRAIN; DOPAMINE; DRUG INTERACTIONS; MALE; MICRODIALYSIS; NEUROPEPTIDES; OLIGOPEPTIDES; PYRIDINES; PYRROLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTOR, SEROTONIN, 5-HT1D; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS;

EID: 0345084489     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00586-X     Document Type: Article

References (45)

1. Benloucif S., Galloway M.P. Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis. Eur. J. Pharmacol. 200:1991;1-8.
2. Benloucif S.B., Keegan M.J., Galloway M.P. Serotonin-facilitated dopamine release in vivo: pharmacological characterization. J. Pharmacol. Exp. Ther. 265:1993;373-377.
3. Benveniste H., Hansen A.J., Ottosen N.S. Determination of brain interstitial concentrations by microdialysis. J. Neurochem. 52:1989;1741-1750.
4. 3 receptors in rat striatum. J. Pharmacol. Exp. Ther. 251:1989;803-809.
5. 3 receptor which modulates the release of 5-HT in the guinea-pig brain. Br. J. Pharmacol. 108:1993;13-22.
6. 3H ]5HT release in the guinea-pig hypothalamus are not autoreceptors Synapse. 15:1993;143-148.
7. 1B heteroreceptors inhibiting acetylcholine release. Eur. J. Pharmacol. 242:1993;1-6.
8. 4 receptor subtype involvement in the enhancement of striatal dopamine release induced by serotonin: a microdialysis study in the halothane-anesthetized rat. Neuropharmacology. 34:1995;269-279.
9. 1B agonists: involvement of the hippocampo-accumbens pathways. Neuropharmacology. 35:1996;1521-1529.
10. Brown E.E., Damsma G., Cumming P., Fibiger H.C. Interstitial 3-methoxytyramine reflects striatal dopamine release: an in vivo microdialysis study. J. Neurochem. 57:1991;701-707.
11. 3 receptor by 1-phenylbiguanide increase dopamine release in the rat nucleus accumbens. Brain Res. 543:1991;354-357.
12. 3 receptor activation in medial prefrontal cortex of freely moving rats. Synapse. 10:1992;264-266.
13. 1 receptor subtypes exhibit distinct G protein coupling behaviors in membranes from Sf9 cells. Biochemistry. 36:1997;12930-12938.
14. 1B receptors Proc. Natl. Acad. Sci. USA. 94:1997;9899-9904.
15. De Deurwaedère P., Bonhomme N., Lucas G., Le Moal M., Spampinato U. Serotonin enhances striatal dopamine outflow in vivo through dopamine uptake sites. J. Neurochem. 66:1996;210-215.
16. q-coupled receptors. Eur. J. Pharmacol. 348:1998;279-285.
17. 1B/1D receptors. Behav. Brain Res. 73:1996;313-317.
18. Galzin A.M., Langer S.Z. Modulation of 5HT release by presynaptic inhibitory and facilitatory 5HT receptors in brain slices. Adv. Biosci. 82:1991;59-62.
19. 1B agonist CP-93,129 facilitates striatal dopamine release in vivo. Synapse. 15:1993;90-92.
20. Göthert, M., Schlicker, E., 1997. Regulation of 5HT release in the CNS by presynaptic 5HT autoreceptors and by 5HT heteroreceptors. In: Baumgarten, H.G., Göthert, M. (Eds.), Handbook of Experimental Pharmacology, Vol. 129, Serotoninergic Neurons and 5HT Receptors in the CNS, Springer, Berlin, Chapter 12, pp. 307-350.
21. Grimaldi B., Fillion M.P., Bonnin A., Rousselle J.C., Massot O., Fillion G. Immunocytochemical localization of neurons expressing 5-HT-moduline in the mouse brain. Neuropharmacology. 36:1997;1079-1087.
22. 3 agonist 2-methyl-5HT on the 5HT system in the rat brain. Synapse. 20:1995;54-67.
23. 1 receptor distinct from 1A, 1B, and 1C subtypes J. Neurochem. 56:1991;221-227.
24. 1B receptor agonist CP-93,129 suppresses rat hippocampal 5-HT release in vivo: comparison with RU-24, 969. Eur. J. Pharmacol. 209:1991;249-252.
25. 3 receptor antagonist. Neuropharmacology. 34:1995;211-215.
26. Iyer R.N., Bradberry C.W. Serotonin-mediated increase in prefrontal cortex dopamine release: pharmacological characterization. J. Pharmacol. Exp. Ther. 227:1996;40-47.
27. Jacobs B.L., Fornals C.A. 5HT and motor control: a hypothesis. Trends Neurosci. 16:1993;346-352.
28. Kapur S., Remington G. Serotonin-dopamine interaction and its relevance to schizophrenia. Am. J. Psychiatry. 153:1996;466-476.
29. 1B) agonist and rotationally restricted phenolic analogue of 5-methoxy-3-(1,2,5,6-tetrahydropyrid-4-yl) indole. J. Med. Chem. 33:1990;2087-2093.
30. 3 receptors in the control of 5HT release in rat hippocampus in vivo. Br. J. Pharmacol. 106:1992;139-142.
31. Massot O., Rousselle J.C., Fillion M.P., Grimaldi B., Cloëz-Tayarani I., Fugelli A., Prudhomme N., Seguin L., Rousseau B., Plantefol M., Hen R., Fillion G. 5-Hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine 1B/1D receptors. Mol. Pharmacol. 50:1996;752-762.
32. 1B receptors mediating inhibition of acetylcholine release. Eur. J. Pharmacol. 129:1986;333-337.
33. Maura G., Fedele E., Raiteri M. Acetylcholine release from rat hippocampal slices is modulated by 5-hydroxytryptamine. Eur. J. Pharmacol. 165:1989;173-179.
34. 1D receptors. Br. J. Pharmacol. 123:1998;45-50.
35. 1B/1D receptor antagonists. Gen. Pharmacol. 29:1997;293-303.
36. Parsons L.H., Justice J.B. Perfusate serotonin increases extracellular dopamine in the nucleus accumbens of the rat as measured by in vivo microdialysis. Brain Res. 606:1993;195-199.
37. Pehek E.A., Bi Y. Ritanserin administration potentiates amphetamine-stimulated dopamine release in the rat prefrontal cortex. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 21:1997;671-682.
38. Rousselle J.C., Massot O., Delepierre M., Zifa E., Rousseau B., Fillion G. Isolation and characterization of an endogenous peptide from rat brain interacting specifically with the serotonergic 1B receptor subtypes. J. Biol. Chem. 271:1996;726-735.
39. Saito H., Matsumoto M., Togashi H., Yoshioka M. Functional interaction between serotonin and other neuronal systems: focus on in vivo microdialysis studies. Jpn. J. Pharmacol. 70:1996;203-225.
40. 1B receptors in the rat. Neurosci. Res. 27:1997;277-280.
41. Ungerstedt, U., 1984. Measurement of neurotransmitter release by intracranial dialysis. In: Marsden, C.A. (Ed.), Measurement of Neurotransmitter Release in Vivo. Wiley, New York, NY, pp. 81-105.
42. 1 receptors in the vertebrate brain. Regional distribution examined by autoradiography. Naunyn-Schmiedeberg's Arch. Pharmacol. 340:1989;486-494.
43. 1A receptors in the rat prefrontal cortex. Eur. J. Pharmacol. 305:1996;73-78.
44. West A.R., Galloway M.P. Regulation of serotonin-facilitated dopamine release in vivo: the role of protein kinase A activating transduction mechanisms. Synapse. 23:1996;20-27.
45. Zetterström T., Sharp T., Collin A.K., Ungerstedt U. In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; Implications for the origin of extracellular DOPAC. Eur. J. Pharmacol. 148:1988;327-334.